Brent Rutland
Chief Tech/Sci/R&D Officer presso KORU MEDICAL SYSTEMS, INC.
Profilo
Brent Rutland is currently the Vice President-Medical Affairs at KORU Medical Systems, Inc. Prior to this, he worked as the Senior Director-Health Outcomes at La Jolla Pharmaceutical Co. from 2018 to 2022.
He also served as the Senior Medical Science Liaison at Baxter International, Inc. from 2016 to 2017.
Mr. Rutland completed his undergraduate degree at Texas A&M University and holds an MBA from the University of Houston.
He also obtained a graduate degree from the University of North Carolina at Chapel Hill.
Posizioni attive di Brent Rutland
Società | Posizione | Inizio |
---|---|---|
KORU MEDICAL SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Brent Rutland
Società | Posizione | Fine |
---|---|---|
LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 01/10/2022 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/07/2017 |
Formazione di Brent Rutland
Texas A&M University | Undergraduate Degree |
University of Houston | Masters Business Admin |
University of North Carolina at Chapel Hill | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
KORU MEDICAL SYSTEMS, INC. | Health Technology |
Aziende private | 1 |
---|---|
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Brent Rutland